Treatment for the endocrine resistant breast cancer: Current options and future perspectives

被引：36
|
作者：
Liu, Chun-Yu [1 ,3 ]
Wu, Chia-Yun [1 ,3 ]
Petrossian, Karineh [4 ]
Huang, Tzu-Ting [1 ]
Tseng, Ling-Ming [2 ,3 ]
Chen, Shiuan [4 ]
机构：
[1] Dept Oncol, Div Med Oncol, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Surg, Taipei, Taiwan
[3] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[4] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, 1500 East Duarte Rd, Duarte, CA 91010 USA
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 2017年 / 172卷
关键词：
Endocrine resistance; Hormone receptor; Estrogen receptor; Breast cancer; ESTROGEN-RECEPTOR-ALPHA; GROWTH-FACTOR RECEPTOR; NONSTEROIDAL AROMATASE INHIBITORS; EVEROLIMUS PLUS EXEMESTANE; PENTOSE-PHOSPHATE PATHWAY; RANDOMIZED PHASE-II; HORMONE-RECEPTOR; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; TAMOXIFEN RESISTANCE;
D O I：
10.1016/j.jsbmb.2017.07.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Endocrine resistance remains a challenge and an unmet need for managing hormone receptor-positive breast cancer. The mechanisms of endocrine resistance are multifaceted and are likely to evolve over time following various single or combination therapies. The purpose of this review article is to provide general understanding of molecular basis of endocrine resistance of breast cancer and to offer comprehensive review on current treatment options and potential new treatment strategies for endocrine resistant breast cancers. Last but not the least, we discuss current challenges and future directions for management of endocrine resistant breast cancers.
引用
收藏
页码：166 / 175
页数：10
相关论文
共 50 条
  • [21] Current Treatment Options for Inflammatory Breast Cancer
    S. Eva Singletary
    [J]. Annals of Surgical Oncology, 1999, 6 : 228 - 229
  • [22] Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
    Pavlovic, Dejan
    Patera, Andriani C.
    Nyberg, Fredrik
    Gerber, Marianne
    Liu, Maggie
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (06) : 255 - 273
  • [23] Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives
    Rozeman, Elisa A.
    Dekker, Tim J. A.
    Haanen, John B. A. G.
    Blank, Christian U.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2018, 19 (03) : 303 - 317
  • [24] Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives
    Elisa A. Rozeman
    Tim J. A. Dekker
    John B. A. G. Haanen
    Christian U. Blank
    [J]. American Journal of Clinical Dermatology, 2018, 19 : 303 - 317
  • [25] Varicella zoster: an update on current treatment options and future perspectives
    Kim, Sharon R.
    Khan, Farhan
    Tyring, Stephen K.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) : 61 - 71
  • [26] Current options and future perspectives for breast margin assessment in clinical practice
    Javaid, Huma
    Marin, Ivan
    Montalvan, Jessica
    Healy, Logan
    Menegaz, Brian
    Hsu, Cary
    Silberfein, Eric
    Bonefas, Elizabeth
    Carter, Stacey A.
    Thompson, Alastair M.
    [J]. CANCER RESEARCH, 2022, 82 (04)
  • [27] Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives
    Gao, Lanwen
    Meng, Fansu
    Yang, Zhenjiang
    Lafuente-Merchan, Markel
    Fernandez, Laura Merino
    Cao, Ye
    Kusamori, Kosuke
    Nishikawa, Makiya
    Itakura, Shoko
    Chen, Junqian
    Huang, Xiaoxun
    Ouyang, Dongfang
    Riester, Oliver
    Deigner, Hans-Peter
    Lai, Haibiao
    Pedraz, Jose Luis
    Ramalingam, Murugan
    Cai, Yu
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [28] Personalized treatment options for thyroid cancer: current perspectives
    Khatami, Fatemeh
    Larijani, Bagher
    Nikfar, Shekoufeh
    Hasanzad, Mandana
    Fendereski, Kiarad
    Tavangar, Seyed Mohammad
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2019, 12 : 235 - 245
  • [29] Endocrine options for Breast Cancer treatment: Looking beyond Tamoxifen
    Toru Watanabe
    Hiroshi Sonoo
    [J]. Breast Cancer, 2000, 7 (4) : 345 - 349
  • [30] Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment
    Kotta-Loizou, Ioly
    Vasilopoulos, Spyridon N.
    Coutts, Robert H. A.
    Theocharis, Stamatios
    [J]. NEOPLASIA, 2016, 18 (11): : 674 - 688
12345